Review Papers- UCHIDA Yasuo -
number of results to view: what to display: sort:
total:23
[2019]
1.中枢疾患時の血液脳関門P糖タンパク質の機能変動機構の解明と中枢関門創薬への新展開.[医学のあゆみ,271(1), (2019), 104-111]内田康雄、臼井拓也、寺崎哲也
2.Uniprotデータベース.[ファルマシア,55(4), (2019), 335]内田康雄
3.次世代型定量プロテオミクスに基づく中枢関門の新規密着結合 分子の同定および多発性硬化症の中枢関門破綻への関与.[ファルマシア,55(4), (2019), 320-324]内田康雄
4.輸送分子夾雑系の再構築に基づくヒト血液脳関門の薬物輸送システムの解明.[CMCB NEWS LETTER, (2019)]内田康雄
[2018]
5.SWATH-MS法って何?優れた定量精度・感度・網羅性を兼ね備えた次世代型定量プロテオミクス.[薬剤学「最近のトピックス」,78(5), (2018), 228-234]内田康雄
[2015]
6.Mass Spectrometry Based Approach for Biomarker Research.[IdenshiIgaku MOOK,in press, (2015)]Toshihiro Yoneyama, Yasuo Uchida, Masanori Tachikawa, Sumio Ohtsuki, Tetsuya Terasaki
[2014]
7.Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics..[Expert Rev Proteomics,11(3), (2014), 303-313]Ohtsuki S, Hirayama M, Ito S, Uchida Y, Tachikawa M, Terasaki T
8.9-year study for prediction of pharmacokinetics, and study abroad toward prediction of drug efficacy and adverse effect.[DMPK News Letter,29(3), (2014), 14-15]Yasuo Uchida
[2013]
9.Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface.[Brain Nerve,65(2), (2013), 121-136]Tachikawa M, Uchida Y, Terasaki T
10.Quantitative targeted absolute proteomics in blood-brain barrier.[Vascular Biology & Medicine,14(4), (2013), 399-409]Y Uchida, K Sato, H Kuroda, Y Hoshi, M Tachikawa, T Terasaki
11.Reconstruction of blood-brain barrier transport function from in vitro system based on quantitative targeted absolute proteomics (QTAP).[Cell Technology,32, (2013), 955-961]Y Uchida, M Tachikawa, T Terasaki
12.Quantitative absolute expression profile of blood-brain barrier transportsome : similarity and difference between animal species, strains and wild/knockout mice.[Brain 21,16(3), (2013), 46-52]Y Uchida, M Tachikawa, Y Hoshi, T Terasaki
13.Quantitative Targeted Absolute Proteomics for the New Horizon of DDS Research.[Progress in Drug Delivery System,22, (2013), 7-12]Tetsuya Terasaki, Yasuo Uchida, Sumio Ohtsuki, Masanori Tachikawa
14.Quantitative targeted absolute proteomics (QTAP)-based rational research on the human blood-brain barrier transport.[Drug Delivery System,28, (2013), 270-278]M Tachikawa, Y Uchida, T Terasaki
[2012]
15.New insight of transporter research based on quantitative targeted absolute proteomics.[Cell Technology,31, (2012), 587-588]Y Uchida, M Tachikawa, T Terasaki
16.LC-MS/MS-based blood-brain barrier transporter study.[Drug Delivery System,27, (2012), 316-317]Yasuo Uchida
[2011]
17.Pharmacoproteomics (PPx)-based blood-brain barrier research.[IdenshiIgaku MOOK,19, (2011), 148-154]Y Uchida, S Ohtsuki and T Terasaki
18.Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects..[J. Pharm. Sci.,100, (2011), 3547-3559]Ohtsuki S, Uchida Y, Kubo Y, Terasaki T
19.Physiological function and expression of transporters at human blood-brain barrier based on quantitative targeted absolute proteomics.[Brain 21,14, (2011), 336-342]M Tachikawa, Y Uchida, S Ohtsuki, T Terasaki
[2010]
20.Laboratory Introduction in University; Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University.[Miyagi Pref. Pharmaceutical Association Kenyaku news,404, (2010), 4-5]Yasuo Uchida
Page: [1] [2] [next]
BackTop
copyright(c)2005 Tohoku University